BRIEF published on 12/13/2024 at 12:02, 3 months 24 days ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/13/2024 at 12:02, 3 months 24 days ago Citigroup réduit sa participation dans GENEURO SA Euronext Paris Franchissement De Seuil Vente D'actions GeNeuro SA Citigroup
PRESS RELEASE published on 12/13/2024 at 11:57, 3 months 24 days ago Franchissement de seuils Déclaration de franchissement de seuils de Citigroup Global Markets Limited concernant GENEURO SA publiée le 12 décembre 2024 Déclaration Franchissement De Seuils GeNeuro SA Citigroup Global Markets Limited
BRIEF published on 12/06/2024 at 18:35, 4 months ago GeNeuro dévoile son nouveau médicament de précision pour la SLA Médecine De Précision GeNeuro Traitement De La SLA GNK-301 ENVIRONNEMENT HERV-K
BRIEF published on 12/06/2024 at 18:35, 4 months ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 4 months ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 4 months ago Informations privilégiées / Autres communiqués Nouvelle approche de médecine de précision pour la SLA avec GNK-301 de GeNeuro présentée au 35e Symposium international sur la SLA/MMN Recherche Médecine De Précision GeNeuro SLA GNK-301
BRIEF published on 11/06/2024 at 09:48, 5 months 1 day ago Franchissement de seuils par Invus Public Equities dans GENEURO SA Euronext Paris Augmentation De Capital Franchissement De Seuils GeNeuro SA Invus Public Equities
BRIEF published on 11/06/2024 at 09:48, 5 months 1 day ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
PRESS RELEASE published on 11/06/2024 at 09:43, 5 months 1 day ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, LP. concernant GENEURO SA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils GeNeuro SA Invus Public Equities
Published on 04/07/2025 at 08:00, 3 hours 50 minutes ago Pulsar Helium Announces Notice of 2025 Annual General and Special Meeting of Shareholders
Published on 04/07/2025 at 00:05, 11 hours 45 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 10 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 11:44, 5 minutes ago EQS-Adhoc: Rubean AG: Change in the Supervisory Board
Published on 04/07/2025 at 11:18, 31 minutes ago Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTES
Published on 04/07/2025 at 10:30, 1 hour 19 minutes ago Original-Research: UmweltBank AG (von GBC AG): Buy
Published on 04/07/2025 at 09:06, 2 hours 44 minutes ago A taboo subject: Younger people talk more openly about their salary than older people — but shy away from negotiation
Published on 04/07/2025 at 09:00, 2 hours 49 minutes ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 17 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
